agilon health, inc. (NYSE:AGL – Get Free Report) Director John William Wulf bought 45,000 shares of the stock in a transaction on Thursday, December 5th. The shares were bought at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the acquisition, the director now owns 206,133 shares in the company, valued at $449,369.94. The trade was a 27.93 % increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
agilon health Stock Up 12.1 %
Shares of NYSE AGL opened at $2.23 on Friday. agilon health, inc. has a 1 year low of $1.50 and a 1 year high of $13.76. The firm has a market cap of $918.80 million, a price-to-earnings ratio of -2.37 and a beta of 0.51. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. The stock’s 50-day simple moving average is $2.46 and its 200-day simple moving average is $4.42.
agilon health (NYSE:AGL – Get Free Report) last announced its earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing the consensus estimate of ($0.10) by ($0.19). The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period in the previous year, the firm earned ($0.06) EPS. As a group, equities analysts anticipate that agilon health, inc. will post -0.5 earnings per share for the current fiscal year.
Institutional Investors Weigh In On agilon health
Analyst Ratings Changes
A number of equities research analysts have commented on the company. Evercore ISI lowered their target price on agilon health from $7.00 to $4.00 and set an “in-line” rating on the stock in a report on Tuesday, October 8th. Citigroup decreased their price objective on agilon health from $2.50 to $1.75 and set a “sell” rating on the stock in a report on Wednesday, November 13th. Barclays decreased their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a report on Monday, November 11th. TD Cowen decreased their price objective on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a report on Monday, November 11th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and issued a $3.00 target price on shares of agilon health in a research report on Tuesday, November 19th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, agilon health currently has an average rating of “Hold” and an average price target of $4.38.
Read Our Latest Research Report on AGL
agilon health Company Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- Are These Liquid Natural Gas Stocks Ready For An Upside Bounce?
- WallStreetBets: How a Reddit Forum Shook Up Stock Market Dynamics
- The Basics of Support and Resistance
- Are 2024’s Top Insider Buys a Good Bet for 2025?
- How to Calculate Inflation Rate
- 4 Social Media Stocks to Soar as TikTok’s Future Hangs in Balance
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.